Unanswered questions regarding the management of sunitinib-induced hypothyroidism

被引：0
|
作者：
David Garfield
Aleck Hercbergs
Paul Davis
机构：
[1] D Garfield is a medical oncologist affiliated with the University of Colorado Health Sciences Center,
[2] A Hercbergs is a Radiation Oncologist at the Cleveland Clinic Foundation,undefined
[3] Cleveland,undefined
[4] OH,undefined
[5] P Davis is Senior Associate Dean for Clinical Research and Professor of Medicine at Albany Medical College,undefined
[6] Albany,undefined
[7] NY,undefined
[8] USA.,undefined
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hypothyroidism seems to be a risk of sunitinib therapy for cancer. The authors of this Viewpoint review the evidence for the occurrence of hypothyroidism in this setting and discuss possible actions of thyroid hormone replacement in the cancer patient.
引用
收藏
页码：674 / 674
相关论文
共 50 条
  • [21] Sunitinib-induced macrocytosis highlighted
    Reactions Weekly, 2007, 1172 (1) : 4 - 4
  • [22] A Rare Case of Sunitinib-Induced Hyperammonemic Encephalopathy and Hypothyroidism in Metastatic Renal Cell Carcinoma
    Pilanci, Kezban Nur
    Elbuken, Filiz
    Ordu, Cetin
    Koksal, Gulistan
    Tekelioglu, Mehmet Hakan
    Okutur, Kerem
    Goksel, Suha
    Koksal, Ulkuhan
    Akcal, Tarik
    Tecimer, Coskun
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (02) : E583 - E587
  • [23] Unanswered Questions Regarding Blood Pressure Management for HF Prevention
    Ramalho, Sergio H. R.
    Shah, Amil M.
    CURRENT HYPERTENSION REPORTS, 2019, 21 (01)
  • [24] Metabolic activation of sunitinib: Implications for sunitinib-induced toxicities
    Jackson, Klarissa D.
    Amaya, Gracia M.
    Durandis, Rebecca
    Wines, Kahari J.
    Abouda, Arsany A.
    Starks, Samuel A.
    Daniels, R. Nathan
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Unanswered Questions Regarding Blood Pressure Management for HF Prevention
    Sergio H. R. Ramalho
    Amil M. Shah
    Current Hypertension Reports, 2019, 21
  • [26] Sunitinib-induced sudden hearing loss
    Kathleen Dekeister
    Emmanuelle Graillot
    Mickaël Durbec
    Jean-Yves Scoazec
    Thomas Walter
    Investigational New Drugs, 2016, 34 : 792 - 793
  • [27] A Case of Sunitinib-Induced Necrotizing Esophagitis
    Bertran-Rodriguez, Carlos E.
    Mony, Shruti
    Slone, Samuel
    Arroyo, Yadis
    Pagan, Andrea
    Rabbanifard, Roshanak
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S963 - S964
  • [28] Imaging sunitinib-induced vascular regression
    Kato, Y.
    Zhu, W.
    Artemov, D.
    Sarkar, S. K.
    Backer, M. V.
    Backer, J. M.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 : 2 - 2
  • [29] Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression
    Kappers, Mariette H. W.
    van Esch, Joep H. M.
    Smedts, Frank M. M.
    de Krijger, Ronald R.
    Eechoute, Karel
    Mathijssen, Ron H. J.
    Sleijfer, Stefan
    Leijten, Frank
    Danser, A. H. Jan
    van den Meiracker, Anton H.
    Visser, Theo J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10): : 3087 - 3094
  • [30] A Case of Sunitinib-Induced Destructive Thyroiditis
    Kim, Bu Kyung
    Choi, Young Sik
    Park, Yo-Han
    ENDOCRINOLOGY AND METABOLISM, 2012, 27 (01) : 68 - 71
12345